MedPath

A research in patients with progressive multiple sclerosis, primary as well as the secondary form. Two groups of patients in which one group of patients receives IVIG medication and the patients of the other group do not receive medication for their progressive multiple sclerosis. With questionnaires we measure if there is a difference in quality of life and fatigue in these two groups of patients.

Recruiting
Registration Number
NL-OMON27216
Lead Sponsor
Self financed study.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

Inclusion criteria group 1 with IVIG:

- Patients with SPMS or PPMS according to the MacDonald criteria

Exclusion Criteria

Exclusion criteria group 1 with IVIG:

- Patients with RRMS or PRMS

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Quality of life and fatigue measured with questionnaires.
Secondary Outcome Measures
NameTimeMethod
EDSS score.
© Copyright 2025. All Rights Reserved by MedPath